<DOC>
	<DOCNO>NCT00640679</DOCNO>
	<brief_summary>The hypothesis test gradual clopidogrel therapy cessation associate superior clinical outcome compare abrupt cessation ( superiority hypothesis ) .</brief_summary>
	<brief_title>Abrupt Versus Tapered Interruption Chronic Clopidogrel Therapy After DES Implantation</brief_title>
	<detailed_description>A possible rebound platelet activity clopidogrel withdrawal suggest patient chronic clopidogrel therapy . However , systematic evaluation role rapid thienopyridine withdrawal ischemic complication patient treat coronary artery disease address specifically design study . The objective study evaluate safety efficacy abrupt taper interruption chronic clopidogrel therapy intracoronary drug-eluting stent implantation .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Patients plan interruption chronic clopidogrel therapy DES implantation Informed , write consent patient Planned surgery within next month Active bleeding reason clopidogrel discontinuation Concomitant coumadin therapy Pregnancy ( present , suspected plan ) positive pregnancy test ( In woman childbearing potential negative pregnancy test mandatory ) Malignancies comorbid condition life expectancy le one year may result protocol noncompliance . Patient 's inability fully comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Drug-eluting Stent</keyword>
</DOC>